GLP1R and atrial flutter: Of note, previous meta-analysis indicated that patients treated with albiglutide was associated with a higher risk of AF or atrial flutter than all-comparators group [47], while other meta-analyses suggested that other GLP1 agonists were not associated with AF, with the only possible exception of albiglutide [48].